ZB
RGEN icon

Zions Bancorporation’s Repligen RGEN Stock Holding History

Zions Bancorporation’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$2.03M Buy
14,079
+4,626
+49% +$663K 0.13% 152
2024
Q3 		$1.41M Buy
9,453
+1,608
+20% +$231K 0.1% 172
2024
Q2 		$989K Sell
7,845
-247
-3% -$38.7K 0.08% 187
2024
Q1 		$1.49M Buy
8,092
+383
+5% +$72.9K 0.11% 159
2023
Q4 		$1.39M Buy
7,709
+605
+9% +$94.2K 0.1% 165
2023
Q3 		$1.13M Buy
7,104
+673
+10% +$110K 0.1% 163
2023
Q2 		$910K Buy
6,431
+63
+1% +$10.1K 0.08% 194
2023
Q1 		$1.07M Buy
6,368
+604
+10% +$108K 0.09% 182
2022
Q4 		$976K Buy
5,764
+904
+19% +$164K 0.08% 167
2022
Q3 		$909K Sell
4,860
-6
-0.1% -$1.26K 0.1% 152
2022
Q2 		$790K Buy
+4,866
New +$770K 0.08% 182
2022
Q1 		– Sell
-150
Closed -$40K – 1168
2021
Q4 		$40K Hold
150
– – ﹤0.01% 497
2021
Q3 		$43K Buy
+150
New +$38.5K ﹤0.01% 470

Other funds holding RGEN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Zions Bancorporation's RGEN Position: Q4 2024 in Review

Zions Bancorporation increased its Repligen (RGEN) stake by 49% in Q4 2024, buying an estimated $663K and bringing the position to 14,079 shares worth $2.03M. The position accounts for 0.13% of the portfolio, ranked #152.

Zions Bancorporation first reported a position in RGEN in Q3 2021 and has held it in 13 quarters since. 431 funds tracked by Wall St. Rank hold RGEN as of Q4 2024.

  • Zions Bancorporation held 14,079 shares of Repligen worth $2.03M as of Q4 2024.
  • Zions Bancorporation bought 4,626 Repligen shares in Q4 2024, an estimated $663K.
  • Repligen made up 0.13% of Zions Bancorporation's portfolio in Q4 2024, its #152 holding.
  • Zions Bancorporation first reported a position in Repligen in Q3 2021 and has held it in 13 quarters since.
  • 431 funds tracked by Wall St. Rank held Repligen as of Q4 2024.

Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.